448 related articles for article (PubMed ID: 19463687)
1. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values.
Fingerhut R
Steroids; 2009 Aug; 74(8):662-5. PubMed ID: 19463687
[TBL] [Abstract][Full Text] [Related]
2. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.
Janzen N; Peter M; Sander S; Steuerwald U; Terhardt M; Holtkamp U; Sander J
J Clin Endocrinol Metab; 2007 Jul; 92(7):2581-9. PubMed ID: 17456574
[TBL] [Abstract][Full Text] [Related]
3. Neonatal screening for congenital adrenal hyperplasia in North-Eastern Italy: a report three years into the program.
Cavarzere P; Camilot M; Teofoli F; Tatò L
Horm Res; 2005; 63(4):180-6. PubMed ID: 15818055
[TBL] [Abstract][Full Text] [Related]
4. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.
Seo JY; Park HD; Kim JW; Oh HJ; Yang JS; Chang YS; Park WS; Lee SY
J Perinat Med; 2014 Jan; 42(1):121-7. PubMed ID: 23989111
[TBL] [Abstract][Full Text] [Related]
5. Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls.
Varness TS; Allen DB; Hoffman GL
J Pediatr; 2005 Oct; 147(4):493-8. PubMed ID: 16227036
[TBL] [Abstract][Full Text] [Related]
6. A case of 11beta-hydroxylase deficiency detected in a newborn screening program by second-tier LC-MS/MS.
Peter M; Janzen N; Sander S; Korsch E; Riepe FG; Sander J
Horm Res; 2008; 69(4):253-6. PubMed ID: 18204274
[TBL] [Abstract][Full Text] [Related]
7. Corrected 17-alpha-hydroxyprogesterone values adjusted by a scoring system for screening congenital adrenal hyperplasia in premature infants.
Lee JE; Moon Y; Lee MH; Jun YH; Oh KI; Choi JW
Ann Clin Lab Sci; 2008; 38(3):235-40. PubMed ID: 18715851
[TBL] [Abstract][Full Text] [Related]
8. Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995.
Balsamo A; Cacciari E; Piazzi S; Cassio A; Bozza D; Pirazzoli P; Zappulla F
Pediatrics; 1996 Sep; 98(3 Pt 1):362-7. PubMed ID: 8784357
[TBL] [Abstract][Full Text] [Related]
9. Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia.
Votava F; Török D; Kovács J; Möslinger D; Baumgartner-Parzer SM; Sólyom J; Pribilincová Z; Battelino T; Lebl J; Frisch H; Waldhauser F;
Eur J Endocrinol; 2005 Jun; 152(6):869-74. PubMed ID: 15941926
[TBL] [Abstract][Full Text] [Related]
10. Monitoring congenital adrenal hyperplasia using blood spot 17-hydroxyprogesterone assay.
Santos CM; Abad LR; Cua SC; Domingo CF
Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():174-8. PubMed ID: 15906729
[TBL] [Abstract][Full Text] [Related]
11. The influence of seasonality and manufacturer kit lot changes on 17α-hydroxyprogesterone measurements and referral rates of congenital adrenal hyperplasia in newborns.
Pearce M; Dauerer E; DiRienzo AG; Caggana M; Tavakoli NP
Eur J Pediatr; 2017 Jan; 176(1):121-129. PubMed ID: 27900477
[TBL] [Abstract][Full Text] [Related]
12. Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia.
Gatelais F; Berthelot J; Beringue F; Descamps P; Bonneau D; Limal JM; Coutant R
Pediatr Res; 2004 Nov; 56(5):701-5. PubMed ID: 15371568
[TBL] [Abstract][Full Text] [Related]
13. No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.
Hird BE; Tetlow L; Tobi S; Patel L; Clayton PE
Arch Dis Child; 2014 Feb; 99(2):158-64. PubMed ID: 24225272
[TBL] [Abstract][Full Text] [Related]
14. [Multicenter investigation on the impact of newborn infants' gestational age and birth weight on the level of 17α-hydroxyprogesterone].
Zhang Q; Wang B; Chen Y; Jiang D; Chen Y
Zhonghua Er Ke Za Zhi; 2014 Sep; 52(9):706-9. PubMed ID: 25476436
[TBL] [Abstract][Full Text] [Related]
15. Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry.
Lacey JM; Minutti CZ; Magera MJ; Tauscher AL; Casetta B; McCann M; Lymp J; Hahn SH; Rinaldo P; Matern D
Clin Chem; 2004 Mar; 50(3):621-5. PubMed ID: 14656905
[TBL] [Abstract][Full Text] [Related]
16. Comparison of one-tier and two-tier newborn screening metrics for congenital adrenal hyperplasia.
Sarafoglou K; Banks K; Gaviglio A; Hietala A; McCann M; Thomas W
Pediatrics; 2012 Nov; 130(5):e1261-8. PubMed ID: 23071209
[TBL] [Abstract][Full Text] [Related]
17. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
Kopacek C; de Castro SM; Prado MJ; da Silva CM; Beltrão LA; Spritzer PM
BMC Pediatr; 2017 Jan; 17(1):22. PubMed ID: 28095810
[TBL] [Abstract][Full Text] [Related]
18. Use of steroid profiling by UPLC-MS/MS as a second tier test in newborn screening for congenital adrenal hyperplasia: the Utah experience.
Schwarz E; Liu A; Randall H; Haslip C; Keune F; Murray M; Longo N; Pasquali M
Pediatr Res; 2009 Aug; 66(2):230-5. PubMed ID: 19390483
[TBL] [Abstract][Full Text] [Related]
19. Screening for congenital adrenal hyperplasia: the Delfia Screening Test overestimates serum 17-hydroxyprogesterone in preterm infants.
al Saedi S; Dean H; Dent W; Stockl E; Cronin C
Pediatrics; 1996 Jan; 97(1):100-2. PubMed ID: 8545200
[TBL] [Abstract][Full Text] [Related]
20. Rapid steroid hormone quantification for congenital adrenal hyperplasia (CAH) in dried blood spots using UPLC liquid chromatography-tandem mass spectrometry.
Janzen N; Sander S; Terhardt M; Steuerwald U; Peter M; Das AM; Sander J
Steroids; 2011 Dec; 76(13):1437-42. PubMed ID: 21839763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
